匯友科技(08088)建議收購以色列公司Gene Sort Ltd. 73.7%股權，最高代價為1395.6422萬美元(約1.0816億港元)，目標公司為於以色列註冊成立之公司，主要從事有關癌症患者基因評估及治療之先進個體化分子診斷服務，將由公司配發共13.52億股代價股份償付；及買方以現金按面值認購認購股份。該股今早一度炒高逾三成至0.076元，最新報0.072元，升幅26.79%，成交金額逾1000萬元。(SY)
(C) Copyright by Infocast Ltd. All Rights Reserved.
Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
阅读更多 http://www.infocastfn.com/fn/ajax/news/newsDetail?newsId=2843661